Results 1 to 10 of about 301,526 (300)

Advances in the application of tumor vaccines and combination strategies: new perspectives in lung cancer treatment [PDF]

Frontiers in Immunology
Lung cancer remains one of the most prevalent and lethal malignancies globally and its treatment has consistently been a focal point of research in the medical field. The emergence of immunotherapies such as immune checkpoint inhibitors has brought about
Lei Sun, Qi Zhao, Liyun Miao
doaj   +2 more sources

Development of Nasal Vaccines and the Associated Challenges

Pharmaceutics, 2022
Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the host via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong mucosal and systemic immunity to combat these infections.
Xuanxuan Nian, Jiayou Zhang, Shihe Huang, Kai Duan, Xinguo Li, Xiaoming Yang   +5 more
doaj   +1 more source

The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review

Vaccines, 2022
Influenza prevention and control has been one of the biggest challenges encountered in the public health domain. The vaccination against influenza plays a pivotal role in the prevention of influenza, particularly for the elderly and small children ...
Jiayou Zhang, Xuanxuan Nian, Xuedan Li, Shihe Huang, Kai Duan, Xinguo Li, Xiaoming Yang   +6 more
doaj   +1 more source

Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza virus that expresses an altered nucleoprotein sequence [PDF]

, 2013
Influenza virus poses a difficult challenge for protective immunity. This virus is adept at altering its surface proteins, the proteins that are the targets of neutralizing antibody.
A Endo, A Portela, AJ McMichael, Alexandria David, Andrew Pekosz, AS McKee, AT Heiny, B Zhou, CJ Wei, CS Ambrose, D Corti, D Grimm, D Zehn, DM Carragher, DT O’Hagan, E de Wit, F Crawford, F Rahman, GA Poland, GE Price, GT Belz, H Hikono, H Hohn, JB Ulmer, JE McElhaney, Jieru Wang, John W. Kappler, JP Christensen, JW Yewdell, K Thueng-in, L Guo, Laura Noges, LE Brown, LL Shu, M Schotsaert, M Wang, Megan K. L. MacLeod, MK MacLeod, MM Cox, MW LaMere, MW Lamere, N Garcon, Niyun Jin, P Marrack, Philippa Marrack, R Sebastian, RA Medina, SL Giannini, T Lambe, TM Wilkinson, U Kees, Y Furuya   +51 more
core   +12 more sources

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence

Emerging Microbes and Infections, 2023
Seasonal influenza, causes hundreds of thousands of deaths annually, posing a severe threat to human health. Currently available influenza vaccines are targeted only at specific strains or conserved epitopes; however, these vaccines are not completely ...
Ning Ma, Zhi-Wu Xia, Zhe-Gang Zhang, Xuan-Xuan Nian, Xue-Dan Li, Zheng Gong, Guo-Mei Zhang, Yang Le, Rong Zhou, Jia-You Zhang, Xiao-Ming Yang   +10 more
doaj   +1 more source

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study

Human Vaccines & Immunotherapeutics, 2023
This phase III clinical trial aimed to assess the safety and demonstrate the immunogenicity of a candidate freeze-dried purified Vero cell-based rabies vaccine (PVRV-WIBP) developed for human use.
Xiaoyuan Huang, Jing Liang, Lili Huang, Xuanxuan Nian, Wei Chen, Jiayou Zhang, Xiao Xu, Xuan Lin, Yue Wang, Jinrong Shi, Lanxin Jia, Qingliang Li, Qianxi Wang, Kai Duan, Xinguo Li, Yaqi Ji, Feixia Peng, Wei Zhang, Zhiqiang Xie, Yanxia Wang, Xiaoming Yang   +20 more
doaj   +1 more source

30-Year Development of Inactivated Virus Vaccine in China

Pharmaceutics, 2023
Inactivated vaccines are vaccines made from inactivated pathogens, typically achieved by using chemical or physical methods to destroy the virus’s ability to replicate.
Jinrong Shi, Ailin Shen, Yao Cheng, Chi Zhang, Xiaoming Yang   +4 more
doaj   +1 more source

Coping Strategies for Pertussis Resurgence

Vaccines, 2023
Pertussis (whooping cough) is a respiratory disease caused primarily by Bordetella pertussis, a Gram-negative bacteria. Pertussis is a relatively contagious infectious disease in people of all ages, mainly affecting newborns and infants under 2 months of
Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan, Xiaoming Yang   +4 more
doaj   +1 more source

Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model

Vaccines, 2023
The resurgence of pertussis in vaccinated communities may be related to the reduced long-term immunity induced by acellular pertussis vaccines. Therefore, developing improved pertussis vaccine candidates that could induce strong Th1 or Th17 cellular ...
Baifeng Yang, Dewu Zhu, Yisi Zhou, Beizhe Gong, Yuan Hu, Jiayou Zhang, Shihe Huang, Xuanxuan Nian, Xinghang Li, Xinguo Li, Kai Duan, Xiaoming Yang   +11 more
doaj   +1 more source

TRAF3 deficiency in MDCK cells improved sensitivity to the influenza A virus

Heliyon, 2023
Tumor necrosis factor receptor-associated factor 3 (TRAF3), an adaptor protein, has significant and varying effects on immunity depending on cell types. The role of TRAF3 in Madin-Darby Canine Kidney Epithelial (MDCK) cell resistance to influenza A virus
Yang Le, Jiayou Zhang, Zheng Gong, Zhegang Zhang, Xuanxuan Nian, Xuedan Li, Daiguan Yu, Ning Ma, Rong Zhou, Guomei Zhang, Bo Liu, Lu Yang, Baiqi Fu, Xiuqin Xu, Xiaoming Yang   +14 more
doaj   +1 more source